News Daily News Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019 Yael L. Maxwell December 20, 2019
News Daily News FDA Approves Icosapent Ethyl for Reducing CVD Events Michael O'Riordan December 13, 2019
News Daily News Many ASCVD Patients Skimp on CV Meds Due to Costs: US Survey Caitlin E. Cox November 25, 2019
News Daily News FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl Michael O'Riordan November 14, 2019
News Daily News Recurrent Events Common Among Young Patients With CAD Michael O'Riordan October 11, 2019
News Daily News New AHA Guidance on Omega-3 Fatty Acids for High Triglycerides Michael O'Riordan August 21, 2019
News Daily News A Boost for Prescription Omega-3s? Not Yet: FDA Panel Set for November Yael L. Maxwell August 14, 2019
News Daily News No Need for Niacin? Meta-analysis Argues the End Is Nigh Yael L. Maxwell April 22, 2019